期刊
JOURNAL OF BIOTECHNOLOGY
卷 180, 期 -, 页码 17-22出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jbiotec.2014.03.026
关键词
Alzheimer disease; Amyloid beta clearance; Catalytic antibody light chain; Metal activation
资金
- National Institutes of Health [R01AG025304, U01AG033183]
- catalytic antibodies and Covalent Bioscience Inc
Catalytic antibodies (catabodies) that degrade target antigens rapidly are rare. We describe the metal-dependence of catabody construct 2E6, an engineered heterodimer of immunoglobulin light chain variable domains that hydrolyzes amyloid beta peptides (A beta) specifically. In addition to the electrophilic phosphonate inhibitor of serine proteases, the metal chelators ethylenediaminetetraacetic acid (EDTA) and 1,10-phenanthroline completely inhibited the hydrolysis of A beta by catabody 2E6. Formation of catabody-electrophilic phosphonate inhibitor adducts was unaffected by EDTA, suggesting that the metal exerts a favorable effect on a catalytic step after the initial catabody nucleophilic attack on Aft The EDTA inactivated catabody failed to disaggregate fibrillar A beta, indicating the functional importance of the A beta hydrolytic activity. Treating the EDTA-inactivated catabody with Zn2+ or Co2+ restored the A beta hydrolytic activity, and Zn2+-induced catabody conformational transitions were evident by fluorescence emission spectroscopy. The studies reveal the absolute catabody dependence on a metal cofactor. (C) 2014 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据